Ripple kopen? Dit zijn de mogelijkheden

Edwards Lifesciences Aandeel

212,04USD -4,63USD -2,14%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Edwards Lifesciences Grafiek - 1 Jaar - NYSE

Taxaties voor Edwards Lifesciences

2018 2019e 2020e 2021e 2022e
Dividend - - - - -
Dividendrendement (in %) - - - - -
K/W-verhouding 31,74 36,17 32,51 28,61 25,74
Winst/Aandeel 4,70 5,34 5,94 6,75 7,50

Nieuws voor Edwards Lifesciences Corp.

Geen nieuws beschikbaar
Meer nieuws

Analisten over Edwards Lifesciences Corp.

meer analisten

Edwards Lifesciences Peer Group

Edwards Lifesciences 212,04
-2,1%
pagehit

Invoer toevoegen

Wat denkt u?

Profiel Edwards Lifesciences Corp.naar bedrijfsprofiel

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..

Aandelenkoers Edwards Lifesciences Corp. in USDPush activeren

Koers 212,04 USD -4,63 -2,14 %
Tijd 22:15:10
Handelsdatum 23.08.2019
Opening 0,00
Slot 216,67
Hoogste 0,00
Laagste 0,00
52 W. Hoog 226,31
52 W. Laag 136,47
52 W. Perf.
Volume (Aantal) 0
Marktkap. (EUR) 41,05 Mrd
Beurs
De koers van 212,04 USD aan de beurs New York komt bij de actuele wisselkoers overeen USD/EUR met een koers van 190,79 Euro.

Naar aandeel Edwards Lifesciences

ISIN US28176E1082
Indices S&P 500

Edwards Lifesciences Kerncijfers

Marktkapitalisatie in Euro 41,05 Mrd
Vrij verhandelbaar in %
Aantal Aandelen 207,97
Kasstroom/Aandeel in lokale valuta 3,90
Boekwaarde/Aandeel in lokale valuta 16,18
60 Dagen Volatiliteit 32,43
K/B verhouding

Edwards Lifesciences Historische koersen

23-8-2019 212,04 288.078
22-8-2019 216,67 470.268
21-8-2019 221,79 197.916
20-8-2019 222,01 284.484
19-8-2019 222,50 377.216